Trulieve's NYSE Listing Is Historic. But Is the Stock Still Worth Buying?
The listing matters, but fundamentals matter more.
Overview
Trulieve Cannabis (NYSE: TRLV) just accomplished something no other U.S. cannabis operator has managed to do.
Earlier this month, the company became the first U.S. plant-touching cannabis business to list on the New York Stock Exchange. That's a significant milestone for an industry that has spent years largely confined to Canadian exchanges and over-the-counter markets.
Details
But while the listing itself is historic, it doesn't necessarily mean you should run out and buy the stock. At least not based on the new listing alone.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.